Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.

Hartweg, J; Perera, R; Montori, V; Dinneen, S; Neil, HA; Farmer, A

Abstract:

BACKGROUND: People with type 2 diabetes mellitus are at increased risk from cardiovascular disease. Dietary omega-3 polyunsaturated fatty acids (PUFAs) are known to reduce triglyceride levels, but their impact on cholesterol levels, glycemic control and vascular outcomes are not well known. OBJECTIVES: To determine the effects of omega-3 PUFA supplementation on cardiovascular outcomes, cholesterol levels and glycemic control in people with type 2 diabetes mellitus. SEARCH STRATEGY: We carried...

Expand abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Hartweg, J., Perera, R., Montori, V., Dinneen, S., Neil, H. A., & Farmer, A. (2008). Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online), 1.

MLA Style

Hartweg, J., et al. “Omega-3 Polyunsaturated Fatty Acids (PUFA) for Type 2 Diabetes Mellitus.” Cochrane Database of Systematic Reviews (Online), no. 1, 2008.

Chicago Style

Hartweg, J, R Perera, V Montori, S Dinneen, HA Neil, and A Farmer. 2008. “Omega-3 Polyunsaturated Fatty Acids (PUFA) for Type 2 Diabetes Mellitus.” Cochrane Database of Systematic Reviews (Online), no. 1.
Tweet
Print